Procedures
have been developed for the purification of pregnant mare serum gonadotropin (PMSG) and its a and jl subunits.
The procedure for the hormone purification involves three steps of column chromatography on Sephadex G-100, DEAE-Sephadex A-50, and hydroxyapatite.
The preparation of subunits involves the dissociation of PMSG with 10 M urea followed by their separation by chromatography on DEAE-Sephadex and Sephadex G-100. Dgalactose (10.6 to 12%) , N-acetylglucosamine (9.0 to 10.5%), N-acetylgalactosamine (3.0 to 3.5%), and sialic acid (12.0 to 14.0%).
The purified PMSG was found to be three times as active as ovine lutropin (LH, Various procedures utilizing commercial preparations have been described for the isolation of PMSG (13) (14) (15) . However, the yields of the purified hormones have been poor, presumably because of the use of low pH buffers in some of the purification schemes. These conditions are not optimal since it has been found that low pH is destructive to glycoprotein hormones, causing the hydrolysis of labile ketosidic bonds of sialic acid (16) . Furthermore, thus far only limited physicochemical, biological, and immunological characterization of PMSG and its subunits has been carried out (13-15, 17, 18) . In this communication, we wish to report methods for the purification of PMSG and its subunits, which not only are reproducible but also give high yields. The methods are suitable for large scale preparations of the hormone and the subunits which are prerequisites for carbohydrate and amino acid sequence studies. In addition, this communication describes the detailed chemical composition, particularly that of the carbohydrate in PMSG and the subunits, and our findings on the molecular weights of the hormone and subunits.
Also discussed are biological and immunological relationships of PMSG and its subunits to hCG, ovine LH, and FSH and their subunits.
RESULTS"

Purification of PMSG
A crude preparation of PMSG (1,660 I.U./mg) was resolved into two peaks on gel filtration on Sephadex G-100 ( Fig. 1 I.U./mg). A 1.9-fold purification was obtained (Table I ). The active fraction was subjected to further purification on a DEAE-Sephadex A-50 column with a discontinuous stepwise gradient. The active material was eluted with 0.15 M NaCl in 0.04 M Tris/P04 buffer. The active fractions (190 to 230 and 260 to 300) were pooled as indicated in Fig. 2 , resulting in two preparations, the first having a potency of 10,300 I.U./mg and the second having a potency of 9,200 I.U./mg ( Table I ). The final purification was achieved with a hydroxyapatite column (Fig. 3) . The material from each active peak in Fig. 2 was subjected separately to chromatography on a hydroxyapatite column. The active fractions from the hydroxyapatite column showed a final activity of 13,740 and 11,330 I.U./mg (material from the first and second active peaks in Fig. 2, respectively) . The activities were determined by both binding and bioassay and they represent a respective 7.6 and 6.6fold increase in purity from the original crude preparation.
The final recovery of activity was 44.2%.
Preparation of Subunits
PMSG was found to consist of two dissimilar subunits, (Y and p, which were separated on the basis of both charge and size. The first separation involved chromatography on DEAESephadex A-50 with a stepwise discontinuous gradient. The urea-dissociated PMSG gave two distinct peaks. The first peak, designated as PMSG-a, appeared with the starting buffer; the second, designated as PMSG-/?, appeared with 0.15 M NaCl in 0.04 M Tris/POd (Fig. 4) . After DEAE-Sephadex A-50 chromatography, the 01 and p subunits were desalted by using a column of Sephadex G-25 (coarse), equilibrated in 0.5% NHdHCOs. The recovery of the p subunit, consistently found in several preparations of the subunits, was about 2 to 3 times that of the (Y subunit by weight. In order to determine whether there was a contamination of PMSG in the fl subunit preparation, the /? subunit was reincubated in urea and rechromatographed on DEAE-Sephadex A-50. Only a single peak was obtained, indicating that the /3 subunit was probably free of contamination from the (Y subunit. The second separation involved the application of a solution of 2.5 mg of the urea-dissociated PMSG to a column of Sephadex G-100 equilibrated with 0.1 M sodium acetate buffer, pH 5.5. Two distinct, well resolved peaks were seen, the first, of the p subunit, being larger according to absorbance at 230 nm than the second, of the cx subunit (Fig. 5) . Recovery according to weight was 1.7 mg for /l and 0.4 mg for (Y. Identification of the (Y and /-I subunits was made by amino sugar analyses of the subunits and compared to analyses of the subunits prepared by chromatography on DEAE-Sephadex A-50. In both cases, the (Y subunit lacked N-acetylgalactosamine, a component of PMSG-/3, indicating that the subunits were free of crosscontamination.
In order to ensure the purity of the subunits, it is advisable to prepare the subunits initially by DEAESephadex chromatography and then subject each subunit, after further teatment with 10 M urea, to additional purification by gel filtration on Sephadex G-100. (Figs. 4 and 5).
Homogeneity of PMSG and Its Subunits
The purity of PMSG was examined by disc and SDS-gel electrophoresis and by the Ouchterlony agar immunodiffusion technique. PMSG was shown to be homogeneous by disc gel electrophoresis in 7% polyacrylamide gel, pH 8.9. gel electrophoresis, PMSG-a! (E) and PMSG-/3 (F) each showed one band, with the ,B subunit moving slower than the (Y subunit (Fig. 6 ). The pattern was repeated when PMSG was run on SDS-gel and then stained for glycoproteins (G). One thin band was seen for PMSG-(Y (H) and a broader, slower moving band was seen for PMSG-P (Fig.  61 ). The broader band of PMSG-/l may result from microheterogeneity in the carbohydrate, particularly due to sialic acid. Also shown in Fig. 6 are SDS-electrophoretic patterns of hCG (J), ovomucoid (K), and al-acid glycoprotein (L) stained with periodic acid-Schiff stain. Examination of PMSG by the Ouchterlony agar diffusion technique showed that PMSG formed a single precipitin line with a high titered antiserum (a dilution of 1: 100.000 bound 50% of the '251-PMSG), thus confirming the homogeneity of PMSG (Fig. 7 ).
Molecular Weights of PMSG and Its Subunits
The molecular weight of the hormone was determined by means of a Ferguson plot (33). A series of five different electrophoretic runs were made in which the total acrylamide concentration was varied from 5.5 to 10% (Fig. 8) . gel concentration versus log RF thus obtained yielded a straight line. The slope of this line designated as the retardation coefficient (KR) was related to the molecular weight as indicated in Fig. 8 . The plots were obtained by using the method of least squares. The average molecular weight of PMSG calculated from two separate experiments was 64,030. The molecular weights of the subunits were determined by a similar method (Fig. 9 ) except that the electrophoresis was carried out in SDS-gels under denaturing conditions as described by Weber and Gsborn (35) . Five gel concentrations varying from 6.5 to 10% were used. The electrophoresis revealed two bands representing a and p subunits. The plots of gel concentration and log RF of both subunits were linear. The slopes of these lines, the retardation coefficients (KR), were plotted as shown in Fig. 9 . The average molecular weights of the (Y and /I subunits from two separate experiments were 16,960 and 43,720, respectively. The molecular weights of PMSG, PMSG-a, and PMSG-/3 were also estimated by gel filtration on Sephadex G-100 using glycoproteins and protein markers for the calibration of the column. When glycoproteins were used as standards, the molecular weights calculated from the plot of log of molecular weight versus V,/V" were 18,500, 57,500, and 65,000 for PMSG-a, PMSG-fi, and PMSG, respectively (Fig. 10) . However, the protein markers gave higher values of 26,000,64,000, and 71,000 for PMSG-a, PMSG-/3, and PMSG, respectively (Fig. 10) .
Amino Acid and Carbohydrate Compositions of PMSG and
Its Subunits Table II describes the chemical compositions of PMSG, hCG (16) , oLH (39) and oFSH (40). Like hCG and other glycoprotein hormones, PMSG is rich in proline and halfcystine. Also notably high are threonine and serine. The carbohydrate moiety of PMSG is made up of sialic acid, Lfucose, D-galactose and D-mannose, N-acetylglucosamine, and N-acetylgalactosamine. Occasionally, D-glucose was observed in PMSG preparations but was found to be a contaminant and could be removed by chromatography on a column of Sephadex G-25 (coarse). The total carbohydrate content of PMSG (uncorrected for water content) was 41.7% and the amounts of sialic acid (14.5%) and galactose (11.6%) were higher than those present in any other glycoprotein hormone (Table II) . The amino acid compositions of the a and p subunits of PMSG show striking differences (Table III) . PMSG-a is rich in lysine and glutamic acid. The p subunit has significantly higher amounts of arginine, serine, proline, alanine, half-cystine, and leucine. In general, the PMSG subunits have similar amino acid patterns as the corresponding subunits of hCG (16) , oLH (39) , and oFSH (40) ( Table III) . The carbohydrate compositions of the' a and fl subunits of PMSG are quite different. The p subunit has a significantly higher content of sialic acid (18.0%), galactose (13.5%), and N-acetylglucosamine (9.9%) ( Table III) and, unlike the (Y subunit, contains Nacetylgalactosamine. The total carbohydrate content of a is 21.5% and that of /I is 46.1% (uncorrected for water content). In carbohydrate content, the PMSG subunits show a closer resemblance to hCG than to the other hormones. While Nacetylgalactosamine is present in the /3 subunits of PMSG and hCG, it is a component of both a and p subunits in other glycoprotein hormones (Table III) .
Biological Properties of PMSG and Its Subunits
FSH and LH activities of PMSG by Bioassay-When highly purified oFSH (115.3 NIH-FSH-SI units/mg) was used as a standard, PMSG had a potency of 66.7% of the standard (Table IV) . Using the ovarian ascorbic acid depletion assay test of Parlow (26), we found that PMSG had approximately 3 times more LH activity than purified oLH (2.3 NIH-LH-SI unita/mg) .
Receptor Binding Activity of PMSG and Other Hormones-In Fig. 11 is shown the dose-response curve for PMSG and its relationship to other hormones in the radioreceptor assay using lz51-PMSG and rat testicular homogenate. Purified hCG and oLH had greater ability than PMSG to compete with lz51-PMSG for the receptor. Fig. 11 and Table V show that purified hCG and oLH have 223.5 and 167.4% mean per cent inhibitory activity, respectively, compared to 100% for pure PMSG. In a reciprocal experiment, it was found that it took 5 times more PMSG than hCG to inhibit the binding of an equivalent amount of '"?-hCG to a testicular homogenate. As shown in Table V , PMSG had a 24.23% mean per cent inhibitory activity compared to 100% for hCG in the hCG radioreceptor assay system. These data agree with those of Gospodarowicz (41), which showed that the ability of the purified PMSG to inhibit '?-LH binding to plasma membranes of bovine corpus luteum was 4 times less than the ability of hCG (20% purified but with a 5-fold correction factor). Also, it was found that there was near identity between PMSG and crude hCG in inhibiting lZ51-PMSG binding to a testicular homogenate (Fig. 11 and Table V, 100% mean per cent inhibitory activity for PMSG and 95.5% for crude hCG) and that oFSH had only 10.5% of the activity of PMSG (Fig.  11 and Table V) . This slight activity shown by oFSH is probably due to contamination by oLH in the preparation.
Receptor Binding Activity of Subunits of PMSG and Their
Hybrids with hCG and oFSH Subunits-The subunits of PMSG and their recombinants were examined for LH and FSH biological activity by their ability to compete with lz51-hCG in binding to the Leydig cells of testes and by their ability to inhibit oFSH binding to a testicular tubule preparation. The individual subunits had virtually no biological activity. Table VI shows that PMSG-(U and PMSG-/s' have 0.02 and 0.05% of PMSG activity, respectively, in the hCG radioreceptor assay and 4.90 and 4.02% of PMSG activity, respectively, in the FSH radioreceptor assay. Upon recombination, the subunits recovered 27.2% of the hCG activity. However, much more of the FSH activity (62.4%) was restored upon recombination.
Also, when PMSG-a was combined with both hCG-/I and oFSH$, there was more hCG (137.3%) and FSH (150.1%) activity in the hybrid than in PMSG alone (Table VI) .
Immunological Properties of PMSG and Its Subunits
Immunological Cross-reactivity of PMSG, PMSG-a, PMSG-/3, oLH, oFSH, and hCG in the ""I-PMSG Anti-PMSG Radioimmunoassay-The standard dose-response curve for PMSG radioimmunoassay displayed as the logit transform of the response variant uersus the log dose of the antigen is shown in Fig. 12 . Ninety per cent of t'he ""I-PMSG used in this assay was precipitable in the presence of excess antibody. Prior to use, the serum was diluted 1:55,000 to bind 50% of the '""I-PMSG.
When a more highly titered antibody was used, it had to be diluted l:lOO,OOO to bind 50% of the lasI-PMSG. Also shown in Fig. 12 on the same logit transform are the inhibition plots for the reconstituted PMSG (PMSG-a + PMSG-P), PMSG-P, PMSG-(Y, oLH (2.3 NIH-LH-SI units/ mg), oFSH (115.3 NIH-FSH-SI units/mg), and highly purified hCG (10,000 l.U./mg) in the PMSG radioimmunoassay system. As summarized in Table VII , the reconstituted PMSG retained 69.9% activity. PMSG-u and PMSG-/? cross-reacted with '""I-PMSG at higher doses with 4.0 and 7.9% of PMSG activity, respectively. Ovine LH, oFSH, and hCG showed nonparallel cross-reactivity at higher doses, with oLH being the most reactive (1.7% of PMSG activity) and hCG the least reactive ((0.07% of PMSG activity, Table VII) .
Immunological Cross-reactvity of PMSG and Its Subunits with the Other Hormones and Their Subunits in the hCG, hCG-a, hCG-P, and hLH Radioimmunoassay Systems-The observation that hCG is least cross-reactive with PMSG is confirmed in reciprocal experiments in which inhibition curves were obtained for PMSG, PMSG-a, and PMSG-/I in hCG, hCG-n, and hCG-/I radioimmunoassay systems. As seen in Fig. 13 and Table VII, after the addition of 20 pg of PMSG, 81.3% of '"'I-hCG was still bound to the antibody. This was equivalent to the inhibitory activity of 0.93 ng of hCG, or PMSG had ~0.01% of the inhibitory activity of hCG in the hCG radioimmunoassay system. Likewise, PMSG-(w even at the 5-pg level did not inhibit '251-hCG-o equivalent to the lowest dose of hCG-cr (0.312 ng). Thus, PMSG-c~ had less than 0.01% the activity of hCG-o (Table VII) in the hCG-a radioimmunoassay system. Larger quantities of PMSG-/I were required, while 0.562 ng of hCG-P was sufiicient to displace 50% of bound '251-hCG-P, i.e. 55 pg of PMSG-fl was needed to displace the same percentage of bound '2'51-hCG-P (Table VII) in the hCG-/3 radioimmunoassay system. Thus, PMSG and its subunits showed some nonparallel cross-reactivity in the hCG, hCG-a, and hCG-/i radioimmunoassay systems. Similarly, lack of cross-reactivity of PMSG was found with hLH in the hLH radioimmunoassay system. Immunological
Cross-reactivity of PMSG and hCG and Their Subunits as Shown by the Ouchterlony Immunodiffusion Technique-Very poor competition between PMSG and hCG was also shown by immunodiffusion experiments. Pure PMSG was placed in the central well of an Ouchterlony plate and anti-hCG-cu, anti-hCG-P, anti-hCG, and anti-PMSG were placed in four evenly spaced wells surrounding it. Only anti-PMSG gave a precipitin line with PMSG (Fig. 7) .
DISCUSSION
PMSG is unique among all glycoprotein hormones because it has both LH and FSH activities contained in the same molecule. It is conceivable that these activities reside in different parts of the molecule. Thus, detailed structural characterization of PMSG should enable us to delineate the regions of its structure specific to each activity by comparison with the known amino acid sequences of hCG (lo-12), LH (42, 43) , and FSH (5-B). The present studies were aimed at: 1) the development of methods for the preparation of the hormone and subunits using experimental conditions which are least deleterious to the hormone or the subunits and 2) the detailed physicochemical, biological, and immunological characterization. The procedure for the purification of the hormone was based on three steps of chromatography on Sephadex G-100, DEAE-Sephadex, and hydroxyapatite. The subunits were prepared by a method similar to the one developed for hCG in our laboratory (44) . Urea-dissociated PMSG was separated into subunits by chromatography on DEAE-Sephadex or Sephadex G-100, or both. These methods yielded homogeneous preparations as determined by electrophoresis in polyacrylamide gel with or without SDS and P-mercaptoethanol (Fig. 6 ) and by immunodiffusion (Fig. 7) . Furthermore, hexosamine analysis of the subunits showed that the subunit preparations had no cross-contamination since, like hCG-/?, PMSG-P was found to have all of the N-acetylgalactosamine present in PMSG. In this respect, PMSG resembles hCG rather than LH, FSH, and thyroid-stimulating hormone in which N-acetylgalactosamine is an integral component of both subunits. In fact, recently it has been found that in the above hormones, the distal N-acetylglucosamine residue is replaced by N-acetylgalactosamine in the chitobiose core (45) of the asparagine-linked carbohydrate units, whereas in hCG or PMSG it serves as a linkage residue in the Ser/Thr-linked carbohydrate units (46, 47) . There are conflicting reports in the literature concerning the molecular weight of PMSG and its subunits. Glycoproteins, as is generally recognized, give erroneous results when subjected to molecular weight determination by SDS-polyacrylamide gel electrophoresis and gel filtration, particularly when the molecular weight markers used are proteins. By using glycoprotein markers we have attempted to determine the molecular weights of PMSG and its subunits by Ferguson plots (33,34). The molecular weight values for PMSG, PMSG-j, and PMSG-a thus obtained were 64,030,43,730, and 16,690, respectively. Thus, contrary to previous reports (13), PMSG consists of subunits of different molecular size. Gospodarowicz reported a value of 53,000 for PMSG and identical molecular weights of 23,000 for each subunit (13). This discrepancy in the data from the two laboratories is probably due to the fact that the p subunit of PMSG does not stain readily with Coomassie blue on SDS-gels (Fig. 6G) . However, it can be visualized clearly by periodic acid-Schiff stain (Fig. 61) . Therefore, failure to detect the fl subunit band would have led to the single band of the a subunit being mistaken for subunits of identical size (compare Gels G and H in Fig. 6 ). Additional evidence in support of dissimilar subunits is that urea-dissociated PMSG resolves on Sephadex G-100, in fact, better than hCG subunits under identical conditions (16) On the other hand, the p subunit of PMSG combines poorly with hCG-cu or oLH-a and oFSH-ru, suggesting that the p subunit of PMSG is hormone-specific and is, therefore, different from that of the other hormones. The radioimmunoassay data only partly support these findings. As expected, PMSG-P does not compete with ""I-hCG-p in an hCG-P radioimmunoassay system. On the other hand, although the cy subunit of PMSG from hybridization experiments would appear to be similar to the other LY subunits, it fails to compete with '""I-hCG-a for antihCG in an hCG-a radioimmunoassay system. Among all glycoprotein hormones, PMSG has the highest content of carbohydrate, almost 50% of the molecule. In other hormones, the content varies from 20 to 33%. The percentage of carbohydrate in the p subunit is twice as great as that present in PMSG-n.
The sialic acid and galactose content of PMSG or PMSG-/? is unusually high. Based on a molecular weight of 60,000, PMSG appears to have 3 L-fucose, 35 Dgalactose, 9 mannose, 25 N-acetyl-D-glucosamine, 9 N-acetyln-galactosamine, and 26 sialic acid residues. Two commonly occurring carbohydrate structural patterns present in animal glycoproteins are: asparagine-linked, complex, sialic acid-containing and serine-linked, N-acetylgalactosamine-containing. If one assumes PMSG has similar structures, the number of mannose residues seems to be less than required by such structures.
Therefore, either the carbohydrate structures in PMSG are different or the mannose value as reported in this paper is low. The possibility of incomplete hydrolysis for neutral sugars determination was ruled out since the mannose value was found to remain unchanged on increasing the time of hydrolysis.
Biologically, the purified PMSG is s as active as highly purified oFSH (115.3 NIH-FSH-SI units/mg) determined by Steelman-Pohley assay (25) and 3 times as active as purified oLH (2.3 NIH-LH-SI units/mg) determined by the ascorbic acid depletion assay. Using in vitro binding assays to determine biological activity of the subunits and of the reconstituted PMSG, it was found that the individual subunits have low biological activity. However, upon recombination there was a significant restoration of the hCG and FSH activity originally in the intact PMSG. Unlike hCG, full biological activity (binding activity) was not regained upon recombination, suggesting that either the optimal conditions for recombination of PMSG subunits have not been determined or possibly that PMSG subunits are less stable than hCG, or both. Like Papkoff (15) , we found that PMSG-cx can combine with hCG-P or FSH-P to yield significant amounts of hCG or FSH activity, respectively, suggesting that a similar (Y subunit is present in glycoprotein hormones and that the fi subunit is the hormone-specific subunit. However, unlike Papkoff (15) (in uivo bioassay), we found that when PMSG-a is combined with both hCG# and oFSH+, there is greater hCG and FSH activity in the hybrid than in PMSG alone (Table VII) .
Human chorionic gonadotropin was found to be least crossreactive with PMSG in the PMSG radioimmunoassay system. Flux and Li (48), using antibody to a crude preparation of PMSG (2,500 I.U./mg), also found no cross-reactivity with hCG in a quantitative precipitin test. Similarly, Schams and Papkoff (14) , using immunodiffusion and immunoelectrophoresis, found no cross-reactivity between hCG and antibody to purified PMSG. However, in the binding assay, hCG and LH were able to inhibit the binding of '""I-PMSG to a testicular homogenate better than PMSG. This is, perhaps, due to greater affinity of hCG or oLH for the receptor than ""I-PMSG. It seems as though the sites in PMSG which determine its biological activity (i.e. binding to the receptor) are similar to other gonadotropins (oLH and hCG) but that these sites are not the principal ones which are involved in binding to the antibody.
In the PMSG radioimmunoassay, we also found nonparallel cross-reactivity of PMSG with oLH and oFSH, the former being more cross-reactive than the latter. Briefly, the present investigations elucidate some of the biological and immunological relationships between PMSG and hCG, oLH and oFSH. It is firmly established that FSH and LH activities are integral components of PMSG molecule. While LH activity, like hCG, is predominant in PMSG, in contrast to hCG, the FSH activity of PMSG is quite substantial. Receptor binding sites in PMSG are similar to those in LH and hCG. The antibody binding or antigenic sites, however, are quite different. The present studies also throw light on the structural relationships between PMSG and hCG, oLH and oFSH. Based on the results of hybridization with hCG-/I and oFSH$, PMSG-a appears to have considerable homology with the (Y subunits of other hormones.
On the other hand, from the inability of the PMSG-P to combine with the LX subunits of other hormones and lack of immunological crossreactivity with hCG-P, it appears that the p subunit is different. Therefore, it probably has lesser amino acid sequence homology with the other p subunits than PMSG-(Y. The size of PMSG-P is considerably larger (2 to 3 times) compared to the other p subunits, which indicates that the problem of structural elucidation is of a different order of magnitude than the other glycoprotein hormones.
The carbohydrate which forms approximately 50% of PMSG-,& again points to the complexity of the structural problem merely because of the size alone. It is interesting to note, however, that all of Nacetylgalactosamine, like hCG, is present in PMSG-P and is involved in the linkage of the carbohydrate units to the serine and threonine residues of the polypeptide chain.:' Finally, it is expected that the present findings will facilitate studies on the complete structural determination of PMSG. 
